Literature DB >> 23161456

Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI.

Shubhabrata Mukherjee1, Emily Trittschuh, Laura E Gibbons, R Scott Mackin, Andrew Saykin, Paul K Crane.   

Abstract

Previous investigators have suggested the existence of distinct cognitive phenotypes of Alzheimer's disease (AD): a dysexecutive subgroup with executive functioning worse than memory and an amnesic subgroup with memory worse than executive functioning. We evaluated data from the AD Neuroimaging Initiative. We assigned people with AD to dysexecutive and amnesic subgroups using single indicators, and analogously using the ADNI-Mem and ADNI-EF composite scores developed using modern psychometric approaches. We evaluated associations between subgroup membership, APOE genotype, and single nucleotide polymorphisms (SNPs) are associated with AD, and brain vascular disease defined as white matter hyperintensities (WMH) and MRI-identified infarcts. We hypothesized that APOE ε4 and alleles associated with higher risk for AD would predict amnesic subgroup membership; alleles associated with higher WMH or infarct burden would predict dysexecutive subgroup membership. Classification agreement between the two approaches was only fair (kappa = 0.23). There was no relationship between APOE alleles and the dysexecutive or amnesic phenotypes defined by either categorization approach. There were 58 AD-related and 25 WMH- or infarct-related SNPs for which odds ratios were > 1.5 or < 0.67 for dysexecutive vs. amnesic subgroup defined by either categorization approach. Higher proportions of SNPs had odds ratios in the hypothesized direction for the subgroups defined by the modern psychometric approach for AD-related (58 % vs. 38 %, p-value < 0.001) and brain vascular disease-related SNPs (48 vs. 32 %, p-value = 0.01). Genetic variation may underlie differential performance in memory and executive functioning among people with AD. Modern psychometric composite scores produced group assignments with more SNP associations in the hypothesized direction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161456      PMCID: PMC3532526          DOI: 10.1007/s11682-012-9207-y

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  30 in total

Review 1.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.

Authors:  Andrew J Saykin; Li Shen; Tatiana M Foroud; Steven G Potkin; Shanker Swaminathan; Sungeun Kim; Shannon L Risacher; Kwangsik Nho; Matthew J Huentelman; David W Craig; Paul M Thompson; Jason L Stein; Jason H Moore; Lindsay A Farrer; Robert C Green; Lars Bertram; Clifford R Jack; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

3.  Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities.

Authors:  I Sánchez-Cubillo; J A Periáñez; D Adrover-Roig; J M Rodríguez-Sánchez; M Ríos-Lago; J Tirapu; F Barceló
Journal:  J Int Neuropsychol Soc       Date:  2009-05       Impact factor: 2.892

4.  Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics.

Authors:  Bradford C Dickerson; David A Wolk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-20       Impact factor: 10.154

5.  Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.

Authors:  Owen Carmichael; Christopher Schwarz; David Drucker; Evan Fletcher; Danielle Harvey; Laurel Beckett; Clifford R Jack; Michael Weiner; Charles DeCarli
Journal:  Arch Neurol       Date:  2010-11

6.  Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR.

Authors:  Christopher Schwarz; Evan Fletcher; Charles DeCarli; Owen Carmichael
Journal:  Inf Process Med Imaging       Date:  2009

Review 7.  Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.

Authors:  Peter T Nelson; Heiko Braak; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-01       Impact factor: 3.685

8.  How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?

Authors:  Jared F Benge; Steve Balsis; Lisa Geraci; Paul J Massman; Rachelle S Doody
Journal:  Dement Geriatr Cogn Disord       Date:  2009-07-30       Impact factor: 2.959

9.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

10.  Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium.

Authors:  Stéphanie Debette; Joshua C Bis; Myriam Fornage; Helena Schmidt; M Arfan Ikram; Sigurdur Sigurdsson; Gerardo Heiss; Maksim Struchalin; Albert V Smith; Aad van der Lugt; Charles DeCarli; Thomas Lumley; David S Knopman; Christian Enzinger; Gudny Eiriksdottir; Peter J Koudstaal; Anita L DeStefano; Bruce M Psaty; Carole Dufouil; Diane J Catellier; Franz Fazekas; Thor Aspelund; Yurii S Aulchenko; Alexa Beiser; Jerome I Rotter; Christophe Tzourio; Dean K Shibata; Maria Tscherner; Tamara B Harris; Fernando Rivadeneira; Larry D Atwood; Kenneth Rice; Rebecca F Gottesman; Mark A van Buchem; Andre G Uitterlinden; Margaret Kelly-Hayes; Mary Cushman; Yicheng Zhu; Eric Boerwinkle; Vilmundur Gudnason; Albert Hofman; Jose R Romero; Oscar Lopez; Cornelia M van Duijn; Rhoda Au; Susan R Heckbert; Philip A Wolf; Thomas H Mosley; Sudha Seshadri; Monique M B Breteler; Reinhold Schmidt; Lenore J Launer; W T Longstreth
Journal:  Stroke       Date:  2009-12-31       Impact factor: 7.914

View more
  7 in total

1.  Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.

Authors:  Kelsey E McLimans; Auriel A Willette
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.

Authors:  Paul K Crane; Emily Trittschuh; Shubhabrata Mukherjee; Andrew J Saykin; R Elizabeth Sanders; Eric B Larson; Susan M McCurry; Wayne McCormick; James D Bowen; Thomas Grabowski; Mackenzie Moore; Julianna Bauman; Alden L Gross; C Dirk Keene; Thomas D Bird; Laura E Gibbons; Jesse Mez
Journal:  Alzheimers Dement       Date:  2017-06-15       Impact factor: 21.566

Review 3.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

4.  Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population.

Authors:  Dana Godrich; Eden R Martin; Gerard Schellenberg; Margaret A Pericak-Vance; Michael Cuccaro; William K Scott; Walter Kukull; Thomas Montine; Gary W Beecham
Journal:  Alzheimers Dement       Date:  2022-02-09       Impact factor: 16.655

5.  The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable.

Authors:  Jesse Mez; Shubhabrata Mukherjee; Timothy Thornton; David W Fardo; Emily Trittschuh; Sheila Sutti; Richard Sherva; John S Kauwe; Adam C Naj; Gary W Beecham; Alden Gross; Andrew J Saykin; Robert C Green; Paul K Crane
Journal:  Neurobiol Aging       Date:  2016-02-21       Impact factor: 4.673

Review 6.  Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers.

Authors:  Li Shen; Paul M Thompson; Steven G Potkin; Lars Bertram; Lindsay A Farrer; Tatiana M Foroud; Robert C Green; Xiaolan Hu; Matthew J Huentelman; Sungeun Kim; John S K Kauwe; Qingqin Li; Enchi Liu; Fabio Macciardi; Jason H Moore; Leanne Munsie; Kwangsik Nho; Vijay K Ramanan; Shannon L Risacher; David J Stone; Shanker Swaminathan; Arthur W Toga; Michael W Weiner; Andrew J Saykin
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

7.  Metabolic Profiling of Cognitive Aging in Midlife.

Authors:  Zhiguang Huo; Brinda K Rana; Jeremy A Elman; Ruocheng Dong; Corinne D Engelman; Sterling C Johnson; Michael J Lyons; Carol E Franz; William S Kremen; Jinying Zhao
Journal:  Front Aging Neurosci       Date:  2020-11-05       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.